Studies have shown that animal models lacking IRS1 developed hyperglycaemia, or Type 2 diabetes mellitus; hence, increasing the protein levels of IRS1 will ultimately reduce the hyperglycemia complications [74]. This evidence concerns the gene IRS1 and type 2 diabetes mellitus.